COVAXIN controversy – is it safe?

On 3rd January 2021, Drug Controller General of India (DGCI)’s approval of two Covid vaccines for restrictive emergency usage in INDIA, has created a lot of controversary. The decision to approve Bharat Biotech Covid-19 vaccine (Covaxin), which is still undergoing phase-3 clinical trials, has raised serious questions, writes Dr Kafeel Khan.     As we entered into a […]